Mechanisms and consequences of persistence of intracellular pathogens: Leishmaniasis as an example

Cellular Microbiology

Volumn 10, Issue 6, 2008, Pages 1221-1234

  Bogdan, Christian ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; HOST PATHOGEN INTERACTION; HOST RESISTANCE; INNATE IMMUNITY; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, PROTOZOAN; CYTOPLASM; HOST-PARASITE INTERACTIONS; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; LEISHMANIA; LEISHMANIASIS; MACROPHAGES; MICE; PHAGOCYTOSIS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

PROTOZOA;

EID: 43449096354     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2008.01146.x     Document Type: Short Survey

References (177)

1. Adak, S., and Datta, A.K. (2005) Leishmania major encodes an unusual peroxidase that is a close homologue of plant ascorbate peroxidase: A novel role of the transmembrane domain. Biochem J 390: 465-474.
2. Aebischer, T., Moody, S.F., and Handman, E. (1993) Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: A possible hazard for the host. Infect Immun 61: 220-226.
3. Almeida-Campos, F.R., and Horta, M.F. (2000) Proteolytic activation of leishporin: Evidence that Leishmania amazonensis and Leishmania guyanensis have distinct inactive forms. Mol Biochem Parasitol 111: 363-375.
4. Amprey, J.L., Späth, G.F., and Porcelli, S.A. (2004) Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani. Infect Immun 72: 589-592.
5. Anderson, C.F., Mendez, S., and Sacks, D.L. (2005) Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major C57BL/ 6 mice. J Immunol 174: 2934-2941.
6. Anderson, C.F., Oukka, M., Kuchroo, V.J., and Sacks, D. (2007) CD4(+) CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204: 285-297.
7. Barr, S.D., and Gedamu, L. (2003) Role of peroxidoxins in Leishmania chagasi survival. Evidence of an enzymatic defense against nitrosative stress. J Biol Chem 278: 10816-10823.
8. Barton, E.S., White, D.W., Cathelyn, J.S., Brett-McClellan, K.A., Engle, M., Diamond, M.S., et al. (2007) Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447: 326-329.
9. Basset, D., Faraut, F., Marty, P., Dereure, J., Rosenthal, E., Mary, C., et al. (2005) Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Microbes Infect 7: 1370-1375.
10. Belkaid, Y. (2007) Regulatory T cells and infection: A dangerous necessity. Nat Rev Immunol 7: 875-888.
11. Belkaid, Y., Hoffmann, K.F., Mendez, S., Kamhawi, S., Udey, M.C., Wynn, T.A., and Sacks, D.L. (2001) The role of interleukin-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 194: 1497-1506.
12. Belkaid, Y., Mendez, S., Lira, R., Kadambi, N., Milon, G., and Sacks, D.L. (2000) A natural model of Leishmania major infection reveals a prolonged 'silent' phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 165: 969-977.
13. Belkaid, Y., von Stebut, E., Mendez, S., Lira, R., Caler, E., Bertholet, S., et al. (2002a) CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J Immunol 168: 3992-4000.
14. + regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
15. Birmingham, C.L., Canadien, V., Kaniuk, N.A., Steinberg, B.E., Higgins, D.E., and Brumell, J.H. (2008) Listeriolysin O allows Listeria monocytogenes replication in macrophage vacuoles. Nature 451: 350-354.
16. Bitsaktsis, C., Nandi, B., Racine, R., MacNamara, K.C., and Winslow, G. (2007) T-Cell-independent humoral immunity is sufficient for protection against fatal intracellular ehrlichia infection. Infect Immun 75: 4933-4941.
17. Blanchette, J., Pouliot, P., and Olivier, M. (2007) Role of protein tyrosine phosphatases in the regulation of interferon-{gamma}-induced macrophage nitric oxide generation: Implication of ERK pathway and AP-1 activation. J Leukoc Biol 81: 835-844.
18. Blos, M., Schleicher, U., Rocha, F.J., Meissner, U., Röllinghoff, M., and Bogdan, C. (2003) Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase. Eur J Immunol 33: 1224-1234.
19. Bogdan, C. (2001) Nitric oxide and the immune response. Nature Immunol 2: 907-916.
20. Bogdan, C. (2004) Reactive oxygen and reactive nitrogen metabolites as effector molecules against infectious pathogens. In The Innate Immune Response to Infection. Kaufmann, S.H.E., Medzhitov, R., and Gordon, S. (eds). Washington, DC: American Society for Microbiology Press, pp. 357-396.
21. Bogdan, C. (2007) Phagocyte effector functions against Leishmania parasites. In Protozoans in Macrophages. Denkers, E.Y., and Gazzinelli, R.T. (eds). Austin, TX: Landes Bioscience, pp. 193-206.
22. Bogdan, C., Vodovotz, Y., and Nathan, C. (1991) Macrophage deactivation by IL-10. J Exp Med 174: 1549-1555.
23. Bogdan, C., Paik, J., Vodovotz, Y., and Nathan, C. (1992) Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem 267: 23301-23308.
24. Bogdan, C., Gessner, A., and Röllinghoff, M. (1993) Cytokines in leishmaniasis: A complex network of stimulatory and inhibitory interactions. Immunobiol 189: 356-396.
25. Bogdan, C., Röllinghoff, M., and Diefenbach, A. (2000a) Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 12: 64-76.
26. Bogdan, C., Donhauser, N., Döring, R., Röllinghoff, M., Diefenbach, A., and Rittig, M.G. (2000b) Fibroblasts as host cells in latent leishmaniosis. J Exp Med 191: 2121-2129.
27. Bopp, T., Becker, C., Klein, M., Klein-Hessling, S., Palmetshofer, A., Serfling, E., et al. (2007) Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 204: 1303-1310.
28. Botha, T., and Ryffel, B. (2002) Reactivation of latent tuberculosis by an inhibitor of inducible nitric oxide synthase in an aerosol murine model. Immunology 107: 350-357.
29. Botha, T., and Ryffel, B. (2003) Reactivation of latent tuberculosis infection in TNF-deficient mice. J Immunol 171: 3110-3118.
30. Bryk, R., Lima, C.D., Erdjument-Bromage, H., Tempst, P., and Nathan, C. (2002) Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein. Science 295: 1073-1077.
31. Buxbaum, L.U., and Scott, P. (2005) Interleukin-10- and Fcγ receptor-deficient mice resolve Leishmania mexicana lesions. Infect Immun 73: 2101-2108.
32. Buxbaum, L.U., Uzonna, J.E., Goldschmidt, M.H., and Scott, P. (2002) Control of New World cutaneous leishmaniasis is IL-12-independent, but STAT4 dependent. Eur J Immunol 32: 3206-3215.
33. Caldwell, H.D., Wood, H., Crane, D., Bailey, R., Jones, R.B., Mabey, D., et al. (2003) Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest 111: 1757-1769.
34. Carrera, L., Gazzinelli, R.T., Badolato, R., Hieny, S., Müller, W., Kühn, R., and Sacks, D.L. (1996) Leishmania promastigotes selectively inhibit interleukin-12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 183: 515-526.
35. Casadevall, A., and Pirofski, L.A. (2006) A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv Immunol 91: 1-44.
36. Chakraborty, D., Banerjee, S., Sen, A., Banerjee, K.K., Das, P., and Roy, S. (2005) Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J Immunol 175: 3214-3224.
37. Chakravortty, D., Hansen-Wester, I., and Hensel, M. (2002) Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J Exp Med 195: 1155-1166.
38. Chan, J., Fujiwara, T., Brennan, P., McNeil, M., Turco, S.J., Sibille, J.-C., etal. (1989) Microbial glycolipids: Possible virulence factors that scavenge oxygen radicals. Proc Natl Acad USA 86: 2453-2457.
39. Chen, W., Jin, W., Hardegen, N., Lei, K.J., Li, L., Marinos, N., et al. (2003) Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
40. Costa, C.H.N., Stewart, J.M., Gomes, R.B.B., Garcez, L.M., Ramos, P.K.S., Bozza, M., et al. (2002) Asymptomatic human carriers of Leishmania chagasi. Am J Trop Med Hyg 66: 334-337.
41. Cotterell, S.E., Engwerda, C.R., and Kaye, P.M. (2000) Leishmania donovani infection of bone marrow stromal macrophages selectively enhances myelopoiesis, by a mechanism involving GM-CSF and TNF-alpha. Blood 95: 1642-1651.
42. Courret, N., Frehel, C., Prina, E., Lang, T., and Antoine, C. (2001) Kinetics of the intracellular differentiation of Leishmania amazonensis and internalization of host MHC molecules by the intermediate parasite stages. Parasitology 122: 263-279.
43. Darwin, K.H., Ehrt, S., Gutierrez-Ramos, J.C., Weich, N., and Nathan, C.F. (2003) The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science 302: 1963-1966.
44. Däubener, W., and MacKenzie, C.R. (1999) IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism. Adv Exp Med Biol 467: 517-524.
45. Davis, A.S., Vergne, I., Master, S.S., Kyei, G.B., Chua, J., and Deretic, V. (2007) Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes. PLoS Pathog 3: 1887-1894.
46. Dereure, J., Thanh, H.D., Lavabre-Bertrand, T., Carton, G., Bastides, F., Richard-Lenoble, D., and Dedet, J.-P. (2003) Visceral leishmaniasis. Persistence of parasites in lymph nodes after clinical cure. J Infect 47: 77-81.
47. El-Gayar, S., Thüring-Nahler, H., Pfeilschifter, J., Röllinghoff, M., and Bogdan, C. (2003) Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages. J Immunol 171: 4561-4568.
48. Fang, F.C. (2004) Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Immunol 2: 820-832.
49. Favali, C., Tavares, N., Clarencio, J., Barral, A., Barral-Netto, M., and Brodskyn, C. (2007) Leishmania amazonensis infection impairs differentiation and function of human dendritic cells. J Leukoc Biol 82: 1401-1406.
50. Finlay, B.B., and McFadden, G. (2006) Anti-immunology: Evasion of the host immune system by bacterial and viral pathogens. Cell 124: 767-782.
51. Fiorentino, D.F., Bond, M.W., and Mosmann, T.R. (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170: 2081-2095.
52. Gandotra, S., Schnappinger, D., Monteleone, M., Hillen, W., and Ehrt, S. (2007) In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice. Nat Med 13: 1515-1520.
53. Gangneux, J.P., Lemenand, O., Reinhard, Y., Guiguen, C., Guguen-Guillouzo, C., and Gripon, P. (2005) In vitro and ex vivo permissivity of hepatocytes for Leishmania donovani. J Eukaryot Microbiol 52: 489-491.
54. Gentry, L.O., and Remington, J.S. (1971) Resistance against Cryptococcus conferred by intracellular bacteria and protozoa. J Infect Dis 123: 22-31.
55. Gerber, J.S., and Mosser, D.M. (2001) Stimulatory and inhibitory signals originating from macrophage Fcγ receptors. Microbes Infection 3: 131-139.
56. Ghosh, S., Goswami, S., and Adhya, S. (2003) Role of superoxide dismutase in survival of Leishmania within the macrophage. Biochem J 369: 447-452.
57. Giudice, A., Camada, I., Leopoldo, P.T., Pereira, J.M., Riley, L.W., Wilson, M.E., et al. (2007) Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in tegumentary leishmaniasis. BMC Infect Dis 7: 7.
58. Grantt, K.R., Goldman, T.L., McCormick, M.L., Miller, M.A., Jeronimo, S.M.B., Nascimento, E.T., et al. (2001) Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol 167: 893-901.
59. Guizani-Tabbane, L., Ben-Aissa, K., Belghith, M., Sassi, A., and Dellagi, K. (2004) Leishmania major amastigotes induce p50/c-Rel NF-kappa B transcription factor in human macrophages: Involvement in cytokine synthesis. Infect Immun 72: 2582-2589.
60. Gupta, A., Gartner, J.J., Sethupathy, P., Hatzigeorgiou, A.G., and Fraser, N.W. (2006) Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442: 82-85.
61. Haidaris, C.G., and Bonventre, P.F. (1982) A role for oxygen-dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages. J Immunol 129: 850-855.
62. Handman, E. (2001) Leishmaniasis: Current status of vaccine development. Clin Microbiol Rev 14: 229-243.
63. Harder, S., Bente, M., Isermann, K., and Bruchhaus, I. (2006) Expression of a mitochondrial peroxiredoxin prevents programmed cell death in Leishmania donovani. Eukaryot Cell 5: 861-870.
64. Holzmuller, P., Sereno, D., and Lemesre, J.-L. (2005) Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum. Antimicrob Agents Chemother 49: 4406-4409.
65. Holzmuller, P., Hide, M., Sereno, D., and Lemesre, J.L. (2006) Leishmania infantum amastigotes resistant to nitric oxide cytotoxicity: impact on in vitro parasite developmental cycle and metabolic enzyme activities. Infect Genet Evol 6: 187-197.
66. Honer zu Bentrup, K., and Russell, D.G. (2001) Mycobacterial persistence: Adaptation to a changing environment. Trends Microbiol 9: 597-605.
67. Hood, C., Cunningham, A.L., Slobedman, B., Arvin, A.M., Sommer, M.H., Kinchington, P.R., and Abendroth, A. (2006) Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons. J Virol 80: 1025-1031.
68. Husain, M., Bourret, T.J., McCollister, B.D., Jones-Carson, J., Laughlin, J., and Vazquez-Torres, A. (2008) Nitric oxide evokes an adaptive response to oxidative stress by arresting respiration. J Biol Chem 283: 7682-7689.
69. Iniesta, V., Carcelen, J., Molano, I., Peixoto, P.M.V., Redondo, E., Parra, P., et al. (2005) Arginase I induction during Leishmania major infection mediates the development of disease. Infect Immun 73: 6085-6090.
70. Jankovic, D., Kullberg, M.C., Feng, C.G., Goldszmid, R.S., Collazo, C.M., Wilson, M., et al. (2007) Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204: 273-283.
71. Ji, J., Sun, J., and Soong, L. (2003) Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun 71: 4278-4288.
72. Jones, D.E., Ackermann, M.R., Wille, U., Hunter, C.A., and Scott, P. (2002) Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect Immun 70: 2151-2158.
73. Kadioglu, A., and Andrew, P.W. (2004) The innate immune response to pneumococcal lung infection: The untold story. Trends Immunol 25: 143-149.
74. Kane, M.M., and Mosser, D.M. (2001) The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166: 1141-1147.
75. Khamesipour, A., Dowlati, Y., Asilian, A., Hashemi-Fesharki, R., Javadi, A., Noazin, S., and Modabber, F. (2005) Leishmanization: Use of an old method for evaluation of candidate vaccines against leishmaniasis. Vaccine 23: 3642-3648.
76. Kima, P.E., Constant, S.L., Hannum, L., Colmenares, M., Lee, K.S., Haberman, A.M., et al. (2000) Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J Exp Med 191: 1063-1067.
77. Kima, P.E., Soong, L., Chicharro, C., Ruddle, N.H., and McMahon-Pratt, D. (1996) Leishmania - infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells. Eur J Immunol 26: 3163-3169.
78. Kropf, P., Fuentes, J.M., Fahnrich, E., Arpa, L., Herath, S., Weber, V., et al. (2005) Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J 19: 1000-1002.
79. Kundig, T.M., Bachmann, M.F., DiPaolo, C., Simard, J.J., Battegay, M., Lother, H., et al. (1995) Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 268: 1343-1347.
80. de La Rosa, R., Pineda, J.A., Delgado, J., Macias, J., Morillas, F., Mira, J.A., et al. (2002) Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy. J Clin Microbiol 40: 762-767.
81. Leclercq, V., Lebastard, M., Belkaid, Y., Louis, J., and Milon, G. (1996) The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice. A tissue-dependent pattern controlled by the Lsh and MHC loci. J Immunol 157: 4537-4545.
82. Lerm, M., Holm, A., Seiron, A., Särndahl, E., Magnusson, K.-E., and Rasmusson, B. (2006) Leishmania donovani requires functional Cdc42 and Rac1 to prevent phagosomal maturation. Infect Immun 74: 2613-2618.
83. van Lint, A.L., Kleinert, L., Clarke, S.R., Stock, A., Heath, W.R., and Carbone, F.R. (2005) Latent infection with herpes simplex virus is associated with ongoing CD8+ T-cell stimulation by parenchymal cells within sensory ganglia. J Virol 79: 14843-14851.
84. Ljungman, P. (2002) Beta-herpesvirus challenges in the transplant recipient. J Infect Dis 186 (Suppl. 1): S99-S109.
85. Lodge, R., and Descoteaux, A. (2005) Leishmania donovani promastigotes induce periphagosomal F-actin accumulation through retention of the GTPase Cdc42. Cell Microbiol 11: 1647-1658.
86. Lodge, R., and Descoteaux, A. (2006) Phagocytosis of Leishmania donovani amastigotes is Rac1 dependent and occurs in the absence of NADPH oxidase activation. Eur J Immunol 36: 2735-2744.
87. Lodge, R., Diallo, T.O., and Descoteaux, A. (2006) Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane. Cell Microbiol 8: 1922-1931.
88. MacMicking, J.D., North, R.J., LaCourse, R., Mudgett, J.S., Shah, S.K., and Nathan, C.F. (1997) Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 94: 5243-5248.
89. Manca, C., Paul, S., Barry, C.E., Freedman, V.H., and Kaplan, G. (1999) Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun 67: 74-79.
90. Martens, S., and Howard, J. (2006) The interferon-inducible GTPases. Annu Rev Cell Dev Biol 22: 559-589.
91. McGuirk, P., McCann, C., and Mills, K.H. (2002) Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasionof protective T helper type 1 responses by Bordetella pertussis. J Exp Med 195: 221-231.
92. McMahon-Pratt, D., and Alexander, J. (2004) Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev 201: 206-224.
93. Meier, C.L., Svensson, M., and Kaye, P.M. (2003) Leishmania -induced inhibition of macrophage antigen presentation at the single-cell level. J Immunol 171: 6706-6713.
94. Mendez, S., Reckling, S.K., Piccirillo, C.A., Sacks, D., and Belkaid, Y. (2004) Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med 200: 201-210.
95. Mendonca, M.G., de Brito, M.E.F., Rodrigues, E.H.G., Bandeira, V., Jardim, M.L., and Abath, F.G.C. (2004) Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: Is there a sterile cure? J Infect Dis 189: 1018-1023.
96. Miles, S.A., Conrad, S.M., Alves, R.G., Jeronimo, S.M.B., and Mosser, D.M. (2005) A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J Exp Med 201: 747-754.
97. Miller, B.H., Fratti, R.A., Poschet, J.F., Timmins, G.S., Master, S.S., Burgos, M., and Marletta, M.A. (2004) Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection. Infect Immun 2004: 2872-2878.
98. Miller, M.A., McGowan, S.E., Gantt, K.R., Champion, M., Novick, S.L., Andersen, K.A., et al. (2000) Inducible resistance to oxidant stress in the protozoan Leishmania chagasi. J Biol Chem 275: 33883-33889.
99. Mills, K.H. (2004) Regulatory T cells: Friend or foe in immunity to infection? Nat Rev Immunol 4: 841-855.
100. Mirkovich, A.M., Galelli, A., Allison, A.C., and Modabber, F.Z. (1986) Increased myelopoiesis during Leishmania major infection in mice: generation of 'safe targets', a possible way to evade the effector immune mechanism. Clin Exp Immunol 64: 1-7.
101. Moll, H. (2000) The role of dendritic cells at the early stages of Leishmania infection. Adv Exp Med Biol 479: 163-173.
102. Monack, D.M., Mueller, A., and Falkow, S. (2004) Persistent bacterial infections: The interface of the pathogen and the host immune system. Nat Rev Microbiol 2: 747-765.
103. Montoya, J.G., and Liesenfeld, O. (2004) Toxoplasmosis. Lancet 363: 1965-1976.
104. Moore, K.W., de Waal Malefyt, R., Coffman, R.L., and O'Garra, A. (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765.
105. Morrison, R.P. (2003) New insights into a persistent problem - chlamydial infections. J Clin Invest 111: 1647-1649.
106. Mosser, D.M., and Brittingham, A. (1997) Leishmania, macrophages and complement: A tale of subversion and exploitation. Parasitology 115: S9-S23.
107. Mukbel, R.M., Patten, C., Jr, Gibson, K., Ghosh, M., Petersen, C., and Jones, D.E. (2007) Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide. Am J Trop Med Hyg 76: 669-675.
108. Munder, M., Eichmann, M., Moran, J.M., Centeno, F., Soler, G., and Modolell, M. (1999) Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol 163: 3771-3777.
109. Munoz-Elias, E.J., and McKinney, J.D. (2005) Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med 11: 638-644.
110. Murphy, M.L., Wille, U., Villegas, E.N., Hunter, C.A., and Farrell, J.P. (2001) IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol 31: 2848-2856.
111. Murray, H.W. (2005) Prevention of relapse after chemotherapy in a chronic intracellular infection: Mechanisms in experimental visceral leishmaniasis. J Immunol 174: 4916-4923.
112. Murray, H.W. (2006) Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase. Am J Trop Med Hyg 74: 1013-1015.
113. Murray, H.W., and Cartelli, D.M. (1983) Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and - independent leishmanicidal activity. J Clin Invest 72: 32-44.
114. Murray, H.W., Lu, C.M., Mauze, S., Freeman, S., Moreira, A.L., Kaplan, G., and Coffman, R.L. (2002) Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect Immun 70: 6284-6293.
115. Murray, H.W., Moreira, A.L., Lu, C.M., DeVecchio, J.L., Matsuhashi, M., Ma, X., and Heinzel, F.P. (2003) Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis. J Infect Dis 188: 458-464.
116. Mysorekar, I.U., and Hultgren, S.J. (2006) Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci USA 103: 14170-14175.
117. Naderer, T., and McConville, M.J. (2008) The Leishmania - macrophage interaction: A metabolic perspective. Cell Microbiol 10: 301-308.
118. Nagase, H., Jones, K.M., Anderson, C.F., and Noben-Trauth, N. (2007) Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility. J Immunol 179: 2435-2444.
119. Niedbala, W., Cai, B., Liu, H., Pitman, N., Chang, L., and Liew, F.Y. (2007) Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+ CD25 T cells via p53, IL-2, and OX40. Proc Natl Acad Sci USA 104: 15478-15483.
120. Noben-Trauth, N., Lira, R., Nagase, H., Paul, W.E., and Sacks, D.L. (2003) The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. J Immunol 170: 5152-5158.
121. Noble, A., Giorgini, A., and Leggat, J.A. (2006) Cytokine-induced IL-10-secreting CD8 T cells represent a phenotypically distinct suppressor T-cell lineage. Blood 107: 4475-4483.
122. Noronha, F.S., Cruz, J.S., Beirao, P.S., and Horta, M.F. (2000) Macrophage damage by Leishmania amazonensis cytolysin: Evidence of pore formation on cell membrane. Infect Immun 68: 4578-4584.
123. Nylen, S., and Sacks, D. (2007) Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28: 378-384.
124. Nylen, S., Maurya, R., Eidsmo, L., Manandhar, K.D., Sundar, S., and Sacks, D. (2007) Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 204: 805-817.
125. Ofek, I., Goldhar, J., Keisari, Y., and Sharon, N. (1995) Nonopsonic phagocytosis of microorganisms. Annu Rev Microbiol 49: 239-276.
126. Olivier, M., Gregory, D.J., and Forget, G. (2005) Subversion mechanisms by which Leishmania parasites can escape the host immune response: A signaling point of view. Clin Microbiol Rev 18: 293-305.
127. Padigel, U.M., and Farrell, J.P. (2005) Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells. J Immunol 174: 6340-6345.
128. Pathania, R., Navani, N.K., Gardner, A.M., Gardner, P.R., and Dikshit, K.L. (2002) Nitric oxide scavenging and detoxification by the Mycobacterium tuberculosis hemoglobin HbN in Escherichia coli. Mol Microbiol 45: 1303-1314.
129. Pham, N.-K., Mouriz, J., and Kima, P.E. (2005) Leishmania pifanoi amastigotes avoid macrophage production of superoxide by inducing heme degradation. Infect Immun 73: 8322-8333.
130. Piddington, D.L., Fang, F.C., Laessig, T., Cooper, A.M., Orme, I.M., and Buchmeier, N.A. (2001) Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst. Infect Immun 69: 4980-4987.
131. Plewes, K.A., Barr, S.D., and Gedamu, L. (2003) Iron superoxide dismutases targeted to the glycosomes of Leishmania chagasi are important for survival. Infect Immun 71: 5910-5920.
132. Price, D.A., Klenerman, P., Booth, B.L., Phillips, R.E., and Sewell, A.K. (1999) Cytotoxic T lymphocytes, chemokines and antiviral immunity. Immunol Today 20: 212-216.
133. Prina, E., Lang, T., Glaichenhaus, N., and Antoine, J.-C. (1996) Presentation of the protective parasite antigen LACK by Leishmania - infected macrophages. J Immunol 156: 4318-4327.
134. Qadoumi, M., Becker, I., Donhauser, N., Röllinghoff, M., and Bogdan, C. (2002) Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous leishmaniosis. Infect Immun 70: 4638-4642.
135. Rittig, M.C., and Bogdan, C. (2000) Leishmania - host cell interaction: complexities and alternative views. Parasitol Today 16: 292-297.
136. Rittig, M., Bogdan, C., and Solbach, W. (1998) Macrophages Infection with Leishmania major. Videotape #C2006. Göttingen: Institut für den Wissenschaftlichen Film.
137. Robertson, C.D. (1999) The Leishmania mexicana proteasome. Mol Biochem Parasitol 103: 49-60.
138. Roy, C.R., and Mocarski, E.S. (2007) Pathogen subversion of cell-intrinsic innate immunity. Nat Immunol 8: 1179-1187.
139. Ruiz, J.H., and Becker, I. (2007) CD8 cytotoxic T cells in cutaneous leishmaniasis. Parasite Immunol 29: 671-678.
140. Ruskin, J., and Remington, J.S. (1968) Immunity and intracellular infection: Resistance to bacteria in mice infected with a protozoan. Science 160: 72-74.
141. Sacks, D.L., and Noben-Trauth, N. (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nature Rev Immunol 2: 845-858.
142. Saeftel, M., Fleischer, B., and Hoerauf, A. (2001) Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infect Immun 69: 2252-2259.
143. Schluter, D., Deckert, M., Hof, H., and Frei, K. (2001) Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii. Infect Immun 69: 7889-7893.
144. Schlüter, D., Deckert-Schlüter, M., Lorenz, E., Meyer, T., Röllinghoff, M., and Bogdan, C. (1999) Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii - susceptible C57BL/6 mice, but does not reactivate the latent disease in T.gondii - resistant BALB/c mice. J Immunol 162: 3512-3518.
145. Schnupf, P., and Portnoy, D.A. (2007) Listeriolysin O: A phagosome-specific lysin. Microbes Infect 9: 1176-1187.
146. Schubach, A., Haddad, F., Neto, M.P.-O., Degrave, W., Pirmez, C., Grimaldi, G., and Fernandes, O. (1998) Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis 178: 911-914.
147. Scott, P. (2005) Immunologic memory in cutaneous leishmaniasis. Cell Microbiol 7: 1707-1713.
148. Shatalin, K., Gusarov, I., Avetissova, E., Shatalina, Y., McQuade, L.E., Lippard, S.J., and Nudler, E. (2008) Bacillus anthracis-derived nitric oxide is essential for pathogen virulence and survival in macrophages. Proc Natl Acad Sci USA 105: 1009-1013.
149. Silva-Jardim, I., Horta, M.F., and Ramalho-Pinto, F.J. (2004) The Leishmania chagasi proteasome: Role in promastigotes growth and amastigotes survival within murine macrophages. Acta Trop 91: 121-130.
150. Soares Rocha, F.J., Schleicher, U., Mattner, J., Alber, G., and Bogdan, C. (2007) Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice. Infect Immun 75: 3823-3832.
151. Sousa-Franco, J., Araujo-Mendes, E., Silva-Jardim, I., Santos, J.L., Faria, D.R., Dutra, W.O., and de Fatima Horta, M. (2006) Infection-induced respiratory burst in BALB/c macrophages kills Leishmania guyanensis amastigotes through apoptosis. Microbes Infection 8: 390-400.
152. Späth, G.F., Garraway, L.A., Turco, S.J., and Beverley, S.M. (2003a) The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc Natl Acad Sci USA 100: 9536-9541.
153. Späth, G.F., Lye, L.-F., Segawa, H., Sacks, D.L., Turco, S.J., and Beverley, S.M. (2003b) Persistence without pathology in phosphoglycan-deficient Leishmania major. Science 301: 1241-1243.
154. + T cells. Eur J Immunol 36: 1764-1771.
155. Stenger, S., Donhauser, N., Thüring, H., Röllinghoff, M., and Bogdan, C. (1996) Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 183: 1501-1514.
156. Stewart, G.R., Robertson, B.D., and Young, D.B. (2003) Tuberculosis: A problem with persistence. Nat Rev Microbiol 1: 97-105.
157. Suffia, I., Reckling, S.K., Salay, G., and Belkaid, Y. (2005) A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol 174: 5444-5455.
158. Suffia, I.J., Reckling, S.K., Piccirillo, C.A., Goldszmid, R.S., and Belkaid, Y. (2006) Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med 203: 777-788.
159. Takeuchi, O., and Akira, S. (2007) Recognition of viruses by innate immunity. Immunol Rev 220: 214-224.
160. Thomas, B.N., and Buxbaum, L.U. (2008) FcγRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions. Infect Immun 76: 623-631.
161. Tiemessen, M.M., Jagger, A.L., Evans, H.G., van Herwijnen, M.J., John, S., and Taams, L.S. (2007) CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA 104: 19446-19451.
162. Uzonna, J.E., Wei, G., Yurkowski, D., and Bretscher, P. (2001) Immune elimination of Leishmania major in mice: Implications for immune memory, vaccination, and reactivation disease. J Immunol 167: 6967-6974.
163. Uzonna, J.E., Joyce, K.L., and Scott, P. (2004) Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. J Exp Med 199: 1559-1566.
164. Vergel, C., Palacios, R., Cadena, H., Posso, C.J., Valderrama, L., Perez, M., et al. (2006) Evidence for Leishmania (Viannia) parasites in the skin and blood of patients before and after treatment. J Infect Dis 194: 503-511.
165. Vieth, M., Will, A., Schröppel, K., Röllinghoff, M., and Gessner, A. (1994) Interleukin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages. Scand J Immunol 40: 403-409.
166. Vodovotz, Y., Russell, D., Xie, Q.-W., Bogdan, C., and Nathan, C. (1995) Vesicle membrane association of nitric oxide synthase in primary mouuse macrophages. J Immunol 154: 2914-2925.
167. Voskuil, M.I., Schnappinger, D., Visconti, K.C., Harrell, M.I., Dolganov, G.M., Sherman, D.R., and Schoolnik, G.K. (2003) Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 198: 705-713.
168. Vouldoukis, I., Bécherel, P.-A., Riveros-Moreno, V., Arock, M., da Silva, O., Debré, P., et al. (1997) Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol 27: 860-865.
169. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C.G., and de Vries, J.E. (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209-1220.
170. Wang, Q., McLoughlin, R.M., Cobb, B.A., Charrel-Dennis, M., Zaleski, K.J., Golenbock, D., et al. (2006) A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J Exp Med 203: 2853-2863.
171. Webb, J.L., Harvey, M.W., Holden, D.W., and Evans, T.J. (2001) Macrophage nitric oxide synthase associates with cortical actin but is not recruited to phagosomes. Infect Immun 69: 6391-6400.
172. Wilhelm, P., Ritter, U., Labbow, S., Donhauser, N., Röllinghoff, M., Bogdan, C., and Körner, H. (2001) Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking tumor necrosis factor. J Immunol 166: 4012-4019.
173. Winthrop, K.L. (2006) Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat Clin Pract Rheumatol 2: 602-610.
174. Woelbing, F., Kostka, S.L., Moelle, K., Belkaid, Y., Sunderkötter, C., Verbeek, S., et al. (2006) Uptake of Leishmania major by dendritic cells is mediated by Fcγ receptors and facilitates acquisition of protective immunity. J Exp Med 203: 177-188.
175. Young, J.D., and McGwire, B.S. (2005) Infliximab and reactivation of cerebral toxoplasmosis. N Engl J Med 353: 1530-1531; discussion 1530-1531.
176. Yurchenko, E., Tritt, M., Hay, V., Shevach, E.M., Belkaid, Y., and Piccirillo, C.A. (2006) CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med 203: 2451-2460.
177. Zaph, C., Uzonna, J., Beverley, S.M., and Scott, P. (2004) Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat Med 10: 1104-1110.